FDA Deviations In Menaflex Knee Device Clearance
In an unusual "preliminary report" released recently, the U.S. Food and Drug Administration admitted to "multiple departures from processes, procedures and practices" in the 510(k) clearance of ReGen Biologics' Menaflex knee...To view the full article, register now.
Already a subscriber? Click here to view full article